Nomogram prediction for the survival of the patients with small cell lung cancer

Hui Pan, Xiaoshun Shi, Dakai Xiao, +8

Journal of Thoracic Disease

The Impact of Anlotinib on Brain Metastases of Non-Small Cell Lung Cancer: Post Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)

Shunjun Jiang, Hengrui Liang, Zhichao Liu, +8

The Oncologist

The Role of NF-E2-Related Factor 2 in Predicting Chemoresistance and Prognosis in Advanced Non–Small-Cell Lung Cancer

Haihong Yang, Wei Wang, Yalei Zhang, +4

Clinical Lung Cancer

Nf-e2-related Factor 2OncologyLung InflammationMedicinePathology +7

RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers

Xueda Hu, Jingyi Chen, Xiaoshun Shi, +9

Tumor Biology

Tumor BiologyNon-small-cell Lung CancersTumor MigrationOncogenic AgentMedicine +13

Sensitive Detection of EGFR Mutations in Cerebrospinal Fluid from Lung Adenocarcinoma Patients with Brain Metastases

Haihong Yang, Linbo Cai, Yalei Zhang, +4

Journal of Molecular Diagnostics

Neuro-oncologyCerebrospinal FluidPathologyBronchial NeoplasmCancer Genetics +5

Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer

Liping Liu, Han Liu, Liu Zu, +20

Genes Chromosomes and Cancer

Erlotinib in combination with pemetrexed/cisplatin for leptomeningeal metastases and cerebrospinal fluid drug concentrations in lung adenocarcinoma patients after gefitinib faliure

Haihong Yang, Xinyun Yang, Yalei Zhang, +5

Targeted Oncology

Leptomeningeal MetastasesMedicineLung Adenocarcinoma PatientsPharmacologyPharmacotherapy +6

The development of targeted therapy in small cell lung cancer.

Yalei Zhang, Jianxing He

PubMed

Aggressive CancerImmunologyTumor BiologyOncologyRadiation Oncology +14

<i>SOX2</i> mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p

Fei Cui, Zhexue Hao, Jin Li, +3

Molecular Genetics & Genomic Medicine

High expression levels of class III β-tubulin in resected non-small cell lung cancer patients are predictive of improved patient survival after vinorelbine-based adjuvant chemotherapy

Yalei Zhang, Haihong Yang, Jun Liu, +10

Oncology Letters

Tumor BiologyClass IiTumor Microtubule ComponentsClass Iii β-TubulinMedicine +13